MAPK15 and neoplasm: Ultimately, we reasoned that, if autophagy represents an important consequence of MAPK15 overexpression for tumorigenesis, then the autophagy-deficient MAPK15_AXXA mutant would confer no advantage for tumor growth in xenograft assays.